Industry News
Miltenyi Biotec acquires gene therapy assets from Lentigen
Global biotechnology company Miltenyi Biotec has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen, a provider of lentiviral technology for cell and gene therapy applications. [ + ]
GE Healthcare appoints BioProcess chief for Asia
GE Healthcare Life Sciences has selected Olivier Loeillot to take on the newly created role of GM Asia commercial for its BioProcess business.
[ + ]National Science Week
This week, Australia celebrates all things science in National Science Week. [ + ]
Bioscience Managers' first fund achieves 24.7% IRR
Bioscience Managers' first fund returned $1.76 per $1 invested, thanks to its portfolio which includes Alchemia (ASX:ACL) Bionomics (ASX:BNO), Acrux (ASX:ACR) and HeartWare (ASX:HIN).
[ + ]Two new national awards
The Australian Academy of Science has announced two new national awards, following a generous donation by immunologist and Corresponding Member (international Fellow) of the academy Professor Sir Marc Feldmann. [ + ]
Academy announces two new science awards
The Australian Academy of Science has announced two new national awards for early- and mid-career researchers, named after pre-eminent scientists Sir Gustav Nossal and Jacques Miller. [ + ]
Tanya Monro appointed chair of the National Youth Science Forum
The new chair of the National Youth Science Forum (NYSF) governing council has been announced as Professor Tanya Monro - an internationally acclaimed physicist who is passionate about improving the community's understanding of the relevance of physics and science in general. [ + ]
Industry leaders propose AIM Incentive to boost innovation
Australian industry leaders have proposed an Australian Innovation & Manufacturing (AIM) Incentive in submissions to the Senate's inquiry into Australia's innovation system. [ + ]
Cracking the code for generating stem cells
Observing the generation of stem cells in zebra fish embryos shows that hematopoietic stem cells are generated with the help of 'buddy' cells. [ + ]
Novogen lines up a double dose of funding
Novogen (ASX:NRT) has won shareholder approval to raise funds to bring drug candidates into clinical trials and support from a FSHD foundation for its regenerative program with Genea Biocells. [ + ]
Perth's Orthocell lists on ASX
Orthocell (ASX:OCC) has listed on the ASX following last month's $8m IPO and started receiving royalty revenue from China for regenerative medicine product Ortho-ACI. [ + ]
Enhancing treatment options for schizophrenia
Discovery of a dimmer switch to control drug action holds promise for the development of next-generation treatments for schizophrenia and other central nervous system disorders. [ + ]
Women in Science Fellows
Three young researchers from Melbourne are the winners of the 2014 L'Oréal Australia & New Zealand for Women in Science Fellowships. [ + ]
Find out what science industry customers actually want
If you want to find out what science industry customers really want, you need to attend Australian Science Industry Exchange on 20 August. [ + ]
Understanding the science market
The SIA's one-day conference, Australian Science Industry Exchange, will give science industry vendors a unique insight into the needs of Australian science industry consumers. [ + ]
